Amy Vanbuskirk

Amy VanBuskirk is an accomplished executive with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as the SVP Global Therapeutic Area Head for Neuroscience and Rare Diseases at Roche since August 2021, Amy previously held the position of Global Product Strategy Franchise Head for Lung, Agnostic, Skin, and Rare Cancers (LASR). Prior roles include General Manager at Roche AB and various leadership positions at Genentech, such as Vice President of the Multiple Sclerosis Franchise and Marketing Director for HCV. Amy's career began at Santen as a Clinical Research Associate. Educational credentials include an MBA from Duke University's Fuqua School of Business and a Bachelor of Science in Zoology from the University of Washington.